kuvura kanseri nshya y'ibihaha kuvura intambwe ya 2020

Ubuvuzi bushya bwo kuvura kanseri y'ibihaha: 2020 na nyuma yayo

Iyi ngingo itanga incamake yiterambere ryingenzi muri kuvura kanseri nshya y'ibihaha kuvura intambwe ya 2020 ndetse no hanze yacyo. Turasesengura iterambere ryingenzi mubuvuzi bugamije, ubudahangarwa bw'umubiri, n'ubundi buryo bushya bwo guhanga udushya, twibanda ku mikorere n'ingaruka zishobora kuvamo ku barwayi. Wige ibijyanye nubushakashatsi buheruka gukorwa hamwe nubuvuzi bukomeje gukorwa byerekana ejo hazaza hitaweho kanseri yibihaha.

Ubuvuzi bugenewe: Ubuvuzi bwuzuye bufata icyiciro cya Centre

Iterambere muri EGFR na ALK Inhibitor

Iterambere rikomeye ryatewe mu buvuzi bugamije, cyane cyane ku barwayi bafite ihinduka ry’imiterere yihariye. Kuvura kanseri y'ibihaha nshya ivura intambwe ya 2020 yabonye ibyemezo byinshi bishya bya EGFR na ALK inhibitor, bitanga umusaruro unoze kandi wihanganirwa ugereranije nibisekuruza byabanje. Iyi miti ihitamo kanseri ya kanseri hamwe niyi ihinduka, igabanya kwangirika kwinyama nzima. Kurugero, iterambere ryigisekuru cya gatatu EGFR inhibitor ryerekanye amasezerano mugutsinda kurwanya imiti ivura mbere. Ubundi bushakashatsi bukomeje gushakisha ubushobozi bwubwo buvuzi bugamije hamwe nubundi buvuzi.

Immunotherapies: Gukoresha imbaraga za sisitemu ya Immune

Inzitizi za Checkpoint n'uruhare rwazo mu kuvura kanseri y'ibihaha

Immunotherapies, ikoresha sisitemu yumubiri yumubiri kugirango irwanye kanseri, yarahindutse kuvura kanseri nshya y'ibihaha kuvura intambwe ya 2020. Inzitizi za Checkpoint, nka PD-1 na PD-L1 inhibitor, zagaragaje intsinzi idasanzwe mu kwagura ubuzima bw'abarwayi ba kanseri y'ibihaha yateye imbere. Iyi miti ihagarika ibimenyetso ingirabuzimafatizo za kanseri zikoresha kugirango birinde ubudahangarwa bw'umubiri, bituma ingirabuzimafatizo zitera no kurimbura ikibyimba. Nyamara, abarwayi bose ntabwo bitabira immunotherapy, kandi ubushakashatsi burakomeje kugirango hamenyekane biomarkers kugirango hamenyekane abarwayi bazungukira byinshi. Byongeye kandi, ubushakashatsi burimo gukora ubushakashatsi ku mikoreshereze y’ubudahangarwa bufatanije n’ubundi buryo bwo kuvura, nka chimiotherapie cyangwa imiti igamije, kugira ngo imikorere irusheho kugenda neza.

Ubundi buryo butanga icyizere

Kwivuza kuvuka hamwe nigeragezwa rya Clinical

Usibye kuvura no gukingira indwara, ubundi buryo butanga ikizere burimo gukorwaho iperereza kuvura kanseri nshya y'ibihaha kuvura intambwe ya 2020. Harimo uburyo bushya bwa chimiotherapie, uburyo bwo kuvura imirasire (nka stereotactique yumubiri radiotherapi cyangwa SBRT), hamwe nuburyo bushya bwo gutanga imiti. Ibigeragezo byinshi byamavuriro birakomeje, gusuzuma imikorere yubuvuzi bushya no gushakisha uburyo bushobora guhuzwa kugirango umusaruro ushimishije. Gukomeza kumenyeshwa ibizamini byubuvuzi birakenewe cyane kubarwayi nimiryango yabo bashaka uburyo bwiza bwo kuvura. Amavuriro.gov nisoko yingirakamaro yo gushakisha amakuru kubigeragezo byubu.

Igihe kizaza cyo kuvura kanseri y'ibihaha

Imiterere yo kuvura kanseri yibihaha ihora itera imbere, hamwe nubushakashatsi niterambere bikomeje gusunika imipaka yibishoboka. Kwishyira hamwe kwa mitiweli, immunotherapie, nubundi buryo bushya bufite isezerano rinini ryo kuzamura umusaruro w’abarwayi n’imibereho yabo. Ni ngombwa ko abantu bahura na kanseri y'ibihaha bagisha inama umuganga wabo wa oncologue kugira ngo baganire ku buryo bukwiye bwo kuvura bujyanye n'imiterere yabo n'imiterere yabo. Kugira ngo ubuvuzi bwuzuye bwa kanseri, tekereza gushakisha ubumenyi buboneka mu bigo nka Shandong Baofa Ikigo Cyubushakashatsi Kanseri.

Kugereranya amakuru: Iterambere ryingenzi ryo kuvura ()

Icyitonderwa: Aya makuru agenewe ubumenyi rusange nintego zamakuru gusa, kandi ntabwo bigize inama zubuvuzi. Buri gihe ujye ubaza inzobere mu by'ubuzima zujuje ibisabwa ku buzima cyangwa mbere yo gufata ibyemezo byose bijyanye n'ubuzima bwawe cyangwa ubuvuzi.